Outcomes of Stem Cell Transplantation in Myelofibrosis
Author Information
Author(s): Patriarca Francesca, Bacigalupo Andrea, Sperotto Alessandra, Isola Miriam, Bruno Barbara, van Lint Maria Teresa, Iori Anna Paola, Di Bartolomeo Paolo, Musso Maurizio, Pioltelli Pietro, Visani Giuseppe, Iacopino Pasquale, Fanin Renato, Bosi Alberto
Primary Institution: Università Cattolica del Sacro Cuore
Hypothesis
What is the outcome of patients with myelofibrosis undergoing allogeneic stem cell transplantation after reduced intensity conditioning regimens?
Conclusion
The presence of circulating blasts and high leukocyte counts before transplantation significantly affected the outcomes after stem cell transplantation.
Supporting Evidence
- The cumulative incidence of engraftment at day 90 after transplant was 83%.
- The estimated 1-year transplant-related mortality was 30%.
- The estimated 3-year event-free survival and overall survival after hematopoietic SCT was 44% and 38%, respectively.
- An higher leukocyte count and circulating blasts in the peripheral blood before SCT significantly reduced event-free survival and overall survival.
Takeaway
Doctors studied patients with a blood disease called myelofibrosis who got special treatments to help them get better. They found that certain blood test results before treatment could help predict how well the treatment would work.
Methodology
Data were collected from 52 patients who underwent transplantation, analyzing clinical features and transplant procedures using statistical methods.
Potential Biases
Potential biases may arise from the retrospective nature of the study and the variability in treatment regimens.
Limitations
The study is limited by the small number of patients and the heterogeneity of transplant procedures.
Participant Demographics
Median age of participants was 52.5 years, with 89% having an intermediate or high Dupriez score.
Statistical Information
P-Value
p=0.001
Confidence Interval
95% CI [1.000011:1.000045]
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website